Category: Acquisitions

Report: Telehealth funding hits record high of $5B

Acquisitions, CB Insights, Companies, Daily, funding, Health Tech, investment, investors, mergers, News, SYN, Telehealth, Telemedicine, Top Story, unicorns, venture capital / August 1, 2021 August 1, 2021

In the second quarter of 2021, the top five deals alone were worth $1.6 billion, representing 30% of the total funding raised. In addition, six telehealth companies joined the unicorn club, including LetsGetChecked and Thirty Madison.

Eli Lilly gets glucose-sensing “smart insulin” via buyout of preclinical Protomer

Acquisitions, Alborz Mahdavi, BioPharma, California, Daily, deals, diabetes, Eli Lilly, Indianapolis, Pasadena, Pharma, Protomer Technologies, SYN, Top Story / July 14, 2021 July 14, 2021

Eli Lilly has Protomer Technologies, a preclinical startup developing next-generation insulin that senses blood glucose levels and adjusts its activity accordingly. The technology could eliminate the need for multiple insulin injections throughout the day.

Biden’s latest executive order aims to boost healthcare competition

Acquisitions, Biden, competition, consolidation, Daily, drug prices, executive order, hearing aids, hospital, hospitals, Legal, mergers, News, Payers, Price Transparency, surprise billing, SYN, Top Story / July 9, 2021 July 9, 2021

President Joe Biden has signed a new executive order to tackle anti-competitive behavior across American industries. With regard to healthcare, Biden is directing federal agencies to revise guidelines for hospital mergers, enable people to comparison shop health plans on the ACA marketplaces and work with states to import drugs from Canada.

Report: Healthcare M&A skewing toward regional partnerships

Acquisitions, activity, Beaumont, Daily, hospitals, Kaufman Hall, mega-mergers, mergers, News, partnerships, regional, Spectrum Health, SYN, Top Story, Transactions / July 8, 2021 July 8, 2021

The total number of mergers and acquisitions in healthcare fell below historic figures for the second quarter of the year, but total transacted revenue remained high at $8.5 billion. Trends appear to be shifting however, with an increasing number of regional partnerships occurring among health systems as opposed to acquisitions of independent hospitals.

Report: Hospitals, insurers, PE firms own nearly half of physician practices

Acquisitions, COVID-19 PANDEMIC, Daily, employed, Health Systems, hospitals, News, owned, Payers, Physician Practices, Physicians, Private Equity, SYN, Top Story / June 29, 2021 June 29, 2021

The Covid-19 pandemic spurred the rate of physician practice acquisition by hospitals and corporate entities, like payers and private equity firms, a new report shows. As a result, by January 2021, about 48% of physician practices across the country were owned by one or the other entity.

Healthcare fintech M&A expected to boost patient experience, provider operations

Acquisitions, benefits, Cedar, consolidation, Daily, Finance, Health IT, News, OODA Health, patients, providers, R1 RCM, Startups, SYN, technology, Top Story, VisitPay / May 27, 2021 May 27, 2021

M&A activity in the healthcare finance technology is heating up, evidenced by large transactions such as Cedar buying OODA Health and R1 RCM buying VisitPay. Experts agree that this activity won’t end anytime soon, and it will have a positive impact on providers and patients.

Report: Fewer health system M&A deals in Q1 2021 offset by larger transactions

Acquisitions, Daily, deals, Health Systems, hospitals, Kaufman Hall, M&A, mega-mergers, merger, News, SYN, Top Story, Transactions / April 12, 2021 April 12, 2021

Though the number of merger and acquisition deals in the first quarter of 2021 fell below historical averages, the size of the deals was far bigger than the same period last year, a new report from Kaufman Hall shows. The total transacted revenue was $8.8 billion, the second-highest Q1 figure in the last five years.

J.P. Morgan’s life sciences outlook for 2021 [Sponsored]

Acquisitions, BioPharma, biopharma nl, Daily, Diagnostics, Health IT, IPO, JP Morgan, News, Peter Meath, sponsored content, Sponsored Post, SYN, Top Story, venture capital / April 1, 2021 April 1, 2021

Peter Meath, J.P. Morgan Commercial Banking’s Co-Head of Healthcare and Life Sciences, applies lessons from 2020’s remarkable second half and shares insights on what to expect in 2021.

Merck sets up Organon spinout with a women’s health medical device acquisition

Acquisitions, Alydia Health, BioPharma, biopharma nl, Daily, Kenilworth, Medical Devices, Merck, New Jersey, Organon, SYN, Top Story, womens health / March 30, 2021 March 30, 2021

Merck agreed to pay $215 million up front to acquire Alydia Health, a startup that has commercialized a medical device that controls bleeding during childbirth. That product will join the portfolio of Merck spinout company Organon.

Grifols reaches across the Atlantic and shells out $450M in a pair of M&A deals

Acquisitions, Barcelona, BioPharma, biopharma nl, COVID-19, Daily, GigaGen, Grifols, Pharma, SYN, Top Story / March 14, 2021 March 14, 2021

Grifols’s acquisition of GigaGen comes as the startup’s Covid-19 antibody drug is set to start Phase 1 testing. Barcelona-based Grifols says GigaGen’s technology could also help it expand to engineered antibody therapies.

Takeda to buy out Maverick in $525M bet on bringing T cells to solid tumors

Acquisitions, BioPharma, biopharma nl, Brisbane, California, cancer immunotherapy, Daily, Maverick Therapeutics, Pharma, SYN, Takeda Pharmaceutical, Top Story / March 9, 2021 March 9, 2021

Takeda Pharmaceutical and Maverick Therapeutics have been R&D partners since 2017. In buying out its partner, Takeda acquires technology and drug candidates that could offer advantages compared to CAR-T therapies, including the potential to treat solid tumors.

Financial strain, new modes of care delivery to drive provider consolidation through 2030

Acquisitions, consolidation, Daily, Health Systems, hospitals, inpatient, mergers, News, outpatient, providers, Revenue, SYN, Top Story, virtual care / December 20, 2020 December 20, 2020

As a result of rapid consolidation, the 10 biggest health systems controlled 24% of market share based on patient revenue by 2018. The trend is expected to continue through the next decade, with health systems facing growing financial pressures and an increase in demand for new types of care delivery.